PNM Resources Inc (PNM) 34.29 $PNM PNM Declares

New Post Public Reply Private Reply Replies (0) Message Board

Jun 13, 2016 at 8:06 PM

PNM Resources Inc (PNM) 34.29 $PNM

PNM Declares Preferred Dividend
PR Newswire - Thu Jun 09, 5:47PM CDT
The Board of Directors of PNM, a subsidiary of PNM Resources (NYSE: PNM), has declared the regular quarterly dividend of $1.145 per share on the 4.58 percent series of cumulative preferred stock. The preferred stock dividend is payable July 15, 2016, to shareholders of record at the close of business July 1, 2016.
PNM: 34.29 (-0.15)

PNM Resources Management to Meet with Investors
PR Newswire - Mon Jun 06, 5:30AM CDT
PNM Resources (NYSE: PNM) management will meet with analysts and investors this week in New York City.
PNM: 34.29 (-0.15)

Interesting PNM Put Options For July 15th
DividendChannel.com - Mon May 23, 9:53AM CDT
Investors in PNM Resources Inc saw new options begin trading today, for the July 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PNM options chain for the new July 15th contracts and identified the...
PNM: 34.29 (-0.15)

NMPRC Orders Extension in PNM General Rate Case Schedule
PR Newswire - Wed May 18, 3:30PM CDT
The New Mexico Public Regulation Commission (NMPRC) today ordered a 30-day extension to the procedural schedule for the general rate case filing submitted by PNM Resources' (NYSE: PNM) New Mexico utility, Public Service Co. of New Mexico (PNM). This order represents the second extension to the schedule and extends the suspension period through August 31, 2016, delaying the earliest implementation of new rates to September 1, 2016.
PNM: 34.29 (-0.15)

PNM Resources Reports First Quarter Results
PR Newswire - Fri Apr 29, 5:30AM CDT
PNM Resources (NYSE: PNM) today released the company's 2016 first quarter earnings results. In addition, management affirmed its 2016 consolidated ongoing earnings guidance of $1.55 to $1.76 per diluted share.
PNM: 34.29 (-0.15)

PNM Resources to Announce 2016 First Quarter Earnings on April 29
PR Newswire - Fri Apr 15, 5:33AM CDT
PNM Resources (NYSE: PNM) will announce 2016 first quarter financial results prior to the market opening on Friday, April 29, 2016. The earnings news release will be issued at 6:30 a.m. Eastern and also will be posted on the company's website at www.PNMResources.com.
PNM: 34.29 (-0.15)

Shares of PNM Up 12.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Mar 07, 10:19AM CST
SmarTrend identified an Uptrend for PNM Resources (NYSE

NM) on November 30th, 2015 at $29.11. In approximately 3 months, PNM Resources has returned 12.44% as of today's recent price of $32.73.
PNM: 34.29 (-0.15)

Volatility Creates Opportunity, Insights on Price Data - Analyst Notes on Cleco, PNM Resources, Hubbell and MarketAxess Holdings
ACCESSWIRE - Fri Mar 04, 7:13AM CST
NEW YORK, NY / ACCESSWIRE / March 4, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Cleco Corp. (NYSE: CNL), PNM Resources Inc. (NYSE: PNM), Hubbell Inc. (NYSE: HUBB) and MarketAxess Holdings Inc. (NASDAQ: MKTX). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
MKTX: 142.07 (+0.23), PNM: 34.29 (-0.15), HUBB: 103.01 (+0.33), CNL: 55.36 (+0.05)

San Juan Mine Sale Finalized
PR Newswire - Mon Feb 01, 3:20PM CST
PNM Resources' (NYSE: PNM) New Mexico Utility, Public Service Co. of New Mexico (PNM), today announced that customer savings have been secured through the finalization of the new coal supply and participant restructuring agreements for the San Juan Generating Station (SJGS). Combined savings from the agreements are expected to reduce customer costs by more than $300 million over six years. This will reduce customer bills by approximately five percent, with retroactive savings implemented as if the new coal contract had become effective in the month of January.
PNM: 34.29 (-0.15), WLB: 9.06 (+0.28)

PNM Resources' Management Reviews 2016 Ongoing Earnings Guidance
PR Newswire - Fri Dec 18, 5:30AM CST
PNM Resources' (NYSE: PNM) management today will discuss the company's 2016 ongoing earnings guidance of $1.55 to $1.76 per diluted share. Expectations for 2016 will be driven by the pending rate case in N.M. Also today, management affirmed the company's 2015 consolidated ongoing earnings guidance of $1.56 to $1.61 per diluted share.
PNM: 34.29 (-0.15)

San Juan Agreement Approved by N.M. Public Regulation Commission
PR Newswire - Wed Dec 16, 2:29PM CST
PNM Resources' (NYSE: PNM) New Mexico Utility, Public Service Co. of New Mexico (PNM), today received approval from the New Mexico Public Regulation Commission (NMPRC) of an agreement that would allow for the retirement of two units at San Juan Generating Station (SJGS). The NMPRC voted 4-1 to approve the NMPRC General Counsel's proposed order for approval of the Hearing Examiner's Nov. 16, 2015 recommended decision.
PNM: 34.29 (-0.15)

Upgrade Alert for PNM Resources (PNM)
Comtex SmarTrend(R) - Tue Dec 15, 7:23AM CST
PNM Resources (NYSE

NM) was upgraded from Hold to Buy at Gabelli & Co today. The stock closed yesterday at $28.48 on volume of 756,000 shares, above average daily volume of 581,000. Potential upside of 9.3% exists for PNM Resources, based on a current level of $28.48 and analysts' average consensus price target of $31.14. PNM Resources shares have support at the 50-day moving average (MA) of $28.34 and additional support at the 200-day MA of $27.10.
PNM: 34.29 (-0.15)

PNM Resources (PNM) Hikes Annual Dividend Rate by 10%
Zacks Equity Research - Zacks Investment Research - Fri Dec 11, 4:00PM CST
The board of directors of electric utility provider, PNM Resources, Inc. (PNM), approved an annual dividend hike of 10% or 8 cents per common share to take the payout to 88 cents per share.
PNM: 34.29 (-0.15), NEE: 123.59 (-0.24), FE: 33.66 (-0.04), WEC: 62.52 (-0.01)

PNM Resources Board Increases Dividend Payment, Declares Quarterly Common Stock Dividend
PR Newswire - Thu Dec 10, 6:08PM CST
At its regular meeting held today, the Board of Directors of PNM Resources (NYSE: PNM) unanimously voted to increase the company's annual dividend payment by $0.08, a 10.0 percent increase, to an indicated annual rate of $0.88 per share of common stock. This is consistent with the company's target to pay out 50 to 60 percent of annual ongoing earnings. The board has declared the resulting quarterly stock dividend of $0.22 per share, payable Feb. 12, 2016, to shareholders of record at the close of business Jan. 25, 2016.
PNM: 34.29 (-0.15)

PNM Resources to Announce 2016 Ongoing Earnings Guidance Dec. 18
PR Newswire - Mon Dec 07, 7:00PM CST
PNM Resources (NYSE: PNM) will announce the company's 2016 ongoing earnings guidance range prior to the market opening on Friday, Dec. 18, 2015. The news release will be issued at 6:30 a.m. Eastern and available on the company's website at www.PNMResources.com.
PNM: 34.29 (-0.15)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Firefox Champions Privacy with Iconic Internet Campaign

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

CapCut's Role in AI-Assisted Small Biz Marketing

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Ivonescimab Promises New Hope for Advanced BTC Patients

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...